|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 16819718.4 (espacenet) (Federated) (European Patent Register), 20161118 | | Patent/reg. no. and date | DK/EP 3377534, 20250618 | | Publication date | 20180926 | | Priority no. and date | US 201562257139 P, 20151118, US 201662345314 P, 20160603 | | EP pub. no. and date |
EP 3377534 20180926 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | PU283452DKQ | | Inventor | FAITH, Nathan E., Rt. 206&Province Line Road
Princeton, New Jersey 08543, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | BEHANDLING AF LUNGECANCER VED HJÆLP AF EN KOMBINATION AF ET ANTI-PD-1-ANTISTOF OG ET ANTI-CTLA-4-ANTISTOF | | Int. application no. | US2016062884 | | Int. publication no. | WO2017087870 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
